Julia Sidenius Johansen

Julia Sidenius Johansen

Clinical Professor

Member of:

  • Clinical Oncology


Publication year:
All
1 - 7 out of 7Page size: 10
  1. 2009
  2. Published

    Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy

    Knudsen, Lene Surland, Hetland, Merete Lund, Johansen, Julia Sidenius, Skjødt, H., Peters, N. D., Colic, A., Grau, K., Nielsen, H. J., Østergaard, Mikkel, Knudsen, L. S., Hetland, M. L., Johansen, J. S., Skjødt, H., Peters, N. D., Colic, A., Grau, K., Nielsen, H. J. & Østergaard, Mikkel, 2009, In: Biomarker Insights. 4, p. 91-5 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease

    Kastrup, J., Johansen, J. S., Winkel, P., Hansen, J. F., Hildebrandt, P., Jensen, G. B., Jespersen, C. M., Kjøller, E., Kolmos, H. J., Lind, I., Nielsen, H., Gluud, C., CLARICOR Trial Group, Kastrup, J., Johansen, J. S., Winkel, P., Hansen, J. F., Hildebrandt, P., Jensen, G. B., Jespersen, C. M. & 6 others, Kjøller, E., Kolmos, H. J., Lind, I., Nielsen, H., Gluud, C. & CLARICOR Trial Group, 2009, In: European Heart Journal. 30, 9, p. 1066-72 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Plasma YKL-40, a new biomarker for atrial fibrillation?

    Henningsen, Kristoffer Mads Aaris, Therkelsen, S. K., Johansen, Julia Sidenius, Bruunsgaard, H. & Svendsen, Jesper Hastrup, 2009, In: Europace. 11, 8, p. 1032-6 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Plasma YKL-40: a potential new cancer biomarker?

    Johansen, Julia Sidenius, Schultz, N. A. & Jensen, B. V., 2009, In: Future Oncology. 5, 7, p. 1065-82 18 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Serum YKL-40 and bone marrow angiogenesis in multiple myeloma

    Mylin, A. K., Andersen, N. F., Johansen, Julia Sidenius, Abildgaard, N., Heickendorff, L., Standal, T., Gimsing, P. & Knudsen, L. M., 2009, In: International Journal of Cancer. 124, 6, p. 1492-4 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    YKL-40 tissue expression and plasma levels in patients with ovarian cancer

    Høgdall, Estrid Vilma Solyom, Ringsholt, M., Høgdall, Claus Kim, Christensen, I. J., Johansen, Julia Sidenius, Kjær, Susanne Krüger, Blaakaer, J., Ostenfeld-Møller, L., Price, P. A. & Christensen, L. H., 2009, In: BMC Cancer. 9, p. 8

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation

    Roslind, A. & Johansen, Julia Sidenius, 2009, In: Methods in Molecular Biology. 511, p. 159-84 26 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 13762833